Wilburn Smith

View Scopus Profile

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Post Doctoral Fellow, Univ Of North Carolina

1994

Residency, Univ Of North Carolina

1987

Doctor of Medicine, Duke University

1982

Bachelor of Arts, Univ Of North Carolina

1978

Fingerprint

Dive into the research topics where Wilburn Smith is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

3 Finished

Metabolic Newborn Screening--FY 2015
Amato, R., Kanga, J. & Smith, W.
KY Cabinet for Health and Family Services
7/1/14 → 6/30/15
Project: Research project
A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mellitus
Karounos, D. & Smith, W.
TKL Research Inc
10/1/08 → 9/30/12
Project: Research project
Genentech National Cooperative Growth Study Post Marketing Surveillance Program for Protropin/Somatrem and Nutropin/ Somatropin
Smith, W.
Genentech Inc
7/1/94 → 12/31/11
Project: Research project

2 Article

Hypothyroidism after Percutaneous Patent Ductus Arteriosus Device Closure in an Extremely Preterm Infant: Possible Role of Iodinated IV Contrast
Piatek, M., Schneider, D. J., Jackson Smith, W., Hanna, M. & Jawdeh, E. G. A., Feb 2021, In: Neonatology. 117, 6, p. 776-779 4 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Gynecomastia in a 15-year-old Boy
Walls, C. A., Jackson Smith, W., Draus, J. M. & Wagner, L. M., Apr 1 2020, In: Pediatrics in Review. 41, 4, p. 206-209 4 p.
Research output: Contribution to journal › Article › peer-review

Wilburn Smith, MD

Personal profile

Education/Academic qualification

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Metabolic Newborn Screening--FY 2015

A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mellitus

Genentech National Cooperative Growth Study Post Marketing Surveillance Program for Protropin/Somatrem and Nutropin/ Somatropin

Hypothyroidism after Percutaneous Patent Ductus Arteriosus Device Closure in an Extremely Preterm Infant: Possible Role of Iodinated IV Contrast

Gynecomastia in a 15-year-old Boy

Wilburn Smith, MD

Personal profile

Education/Academic qualification

Fingerprint

Collaborations and top research areas from the last five years

Grants and Contracts

Metabolic Newborn Screening--FY 2015

A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mellitus

Genentech National Cooperative Growth Study Post Marketing Surveillance Program for Protropin/Somatrem and Nutropin/ Somatropin

Research output

Hypothyroidism after Percutaneous Patent Ductus Arteriosus Device Closure in an Extremely Preterm Infant: Possible Role of Iodinated IV Contrast

Gynecomastia in a 15-year-old Boy